By: Azia Tariq, Staff Editor - Truly personalized medication is the goal of researchers in the pharmaceutical and biotechnological industries.…
By: Hayeon Na, Co-Copy Editor [Content-Focused] - On October 8th of 2013, Bayer’s new drug riociguat (Adempas®) was approved for…
By: Aleena Cherian, Co-Copy Editor [Graphics-Focused] and Jenny Prakash, PharmD Candidate c/o 2014 - Starting your rotations in 5th year…
By: Sang Hyo Kim, Staff Editor - Near the end of December, the pharmaceutical company, MannKind Corp, will submit their…
By: Hayeon Na, Co-Copy Editor [Content-Focused] - The Food and Drug Administration (FDA) announced on July 26th that oral dosage…
By: Alexandra Alleva, PharmD candidate c/o 2013 - As of December 28th, Bristol-Myers Squibb and Pfizer's brand name oral anticoagulant,…
By: Eugene Kolomiyets, PharmD Candidate c/o 2013, AMSCOP at LIU - Cystic fibrosis (CF) is an autosomal recessive disease caused…
By: Neal Shah, Co-Editor-in-Chief - Xerostomia, commonly known as dry mouth, is an anti-muscarinic side effect of numerous medications. Antidepressants,…
By: Mohamed Dungersi & Mahdieh Danesh Yazdi, Associate Student Editors - Each month, the editors at the Rho Chi Post…
By: Mohamed Dungersi, Associate Student Editor - Dr. William Maidhof is an Assistant Professor and Industry Professional in the Clinical…
By: Alexandra Alleva, Pharm.D. Candidate c/o 2013 - On February 17, 2012, the US Food and Drug Administration (FDA) approved…
By: Ebey P. Soman - The FDA recently approved a combination tablet of linagliptin with metformin hydrochloride (Jentadueto®) for the…
By: Aleena Chacko, Long Island University Pharm.D. Candidate c/o 2013 - Established in 1996, Novartis International AG is a multinational…